2 min read
Press Releases
2 min read
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
June 3, 2020 at 4:00 AM
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
June 1, 2020 at 3:00 PM
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
May 20, 2020 at 11:00 PM
2 min read
AGC Biologics to Participate in First-Ever BIO Digital Conference
May 13, 2020 at 6:16 PM
2 min read
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
May 5, 2020 at 1:47 PM
AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab
April 29, 2020 at 3:49 PM
2 min read
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
April 24, 2020 at 5:00 AM
2 min read
AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed
March 17, 2020 at 9:54 AM